Mylan Signs Deal With Indian Firm To Develop 22 Oral Contraceptives
Main Category: Sexual Health / STDsAlso Included In: Pharma Industry / Biotech Industry
Article Date: 11 Aug 2008 - 8:00 PDT
email to a friend 
printer friendly 
opinions
| Patient / Public: |  | |
| Healthcare Prof: | |
Mylan on Wednesday announced a deal with Indian drug maker Famy Care to develop and sell 22 generic oral contraceptive products, the Pittsburgh Tribune-Review reports (Stouffer, Pittsburgh Tribune-Review, 8/7). Mylan plans to seek FDA approval for the products over the next few months and hopes to begin marketing them in 2010. Under the terms of the deal, Mylan can sell other contraceptives in other markets, including Australia and Japan. Mylan did not disclose financial terms of the deal (AP/Yahoo! News, 8/6).
Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.
© 2008 The Advisory Board Company. All rights reserved.
Visit our sexual health / stds section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/117880.php>
APA
http://www.medicalnewstoday.com/releases/117880.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Privacy Policy |
Terms and Conditions
MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
